|
מידע מוסדר
Nyxoah - פרסום הנוגע להודעות שקיפות
מונט-סנט-גיברט, בלגיה, 18 בנובמבר 2024, (GLOBE NEWSWIRE) :
בהתאם לסעיף 14 לחוק מ-2 במאי 2007 על שקיפות בעלי מניות גדולים, Nyxoah SA (נאסד"ק/יורונקסט בריסל: (NYXH מודיעה כי קיבלה הודעת שקיפות כמפורט להלן.
ב-15 בנובמבר 2024 קיבלה Nyxoah הודעת שקיפות מחברת ResMed Inc בעקבות חציית סף פסיבית. בהתבסס על ההודעה, ResMed Inc מחזיקה ב-1,727,864 זכויות הצבעה, המהוות 4.62% מכלל זכויות ההצבעה ב-9 באוקטובר 2024 (37,389,015).
REGULATED INFORMATION
Publication relating to transparency notifications
Mont-Saint-Guibert (Belgium), November 18, 2024, (GLOBE NEWSWIRE):
In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received a transparency notification as detailed below.
On November 15, 2024, Nyxoah received a transparency notification from ResMed Inc. following the passive crossing of a threshold. Based on the notification, ResMed Inc. holds 1,727,864 voting rights, representing 4.62% of the total number of voting rights on October 9, 2024 (37,389,015).
The notification dated November 5, 2024 contains the following information:
-
Reason for the notification: passive crossing of a threshold
-
Notification by: a person that notifies alone
-
Persons subject to the notification requirement:
-
ResMed Inc. (with address at 9001 Spectrum Center Boulevard, San Diego, CA 92123, USA)
Date on which the threshold was crossed: October 9, 2024 Threshold that is crossed: 5% Denominator: 37,389,015 Notified details:
|
A) Voting rights
|
Previous notification
|
After the transaction
|
|
|
# of voting rights
|
# of voting rights
|
% of voting rights
|
|
Holders of voting rights
|
|
Linked to securities
|
Not linked to the securities
|
Linked to securities
|
Not linked to the securities
|
|
ResMed Inc.
|
1,619,756
|
1,727,864
|
|
|
|
|
|
TOTAL
|
1,727,864
|
0
|
4.62%
|
0.00%
|
-
Full chain of controlled undertakings through which the holding is effectively held: No indirect holding of voting securities. ResMed Inc. is not a controlled entity.
Contact:
Nyxoah
John Landry, CFO
[email protected]
Attachment
*** הידיעה מופצת בעולם על ידי חברת התקשורת הבינלאומית GlobeNewswire
לפרטים נוספים: נוי תקשורת 03-6026026 זהר 052-2641769
|
